Simplex Trading
NERV icon

Simplex Trading’s Minerva Neurosciences NERV Stock Holding History

Simplex Trading’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-251
Closed – – 10549
2022
Q2 		$0 Buy
251
+245
+4,083% +$1K ﹤0.01% 10685
2022
Q1 		$0 Buy
+6
New +$37 ﹤0.01% 11065
2021
Q2 		– Sell
-454
Closed -$9.77K – 10467
2021
Q1 		$10K Sell
454
-22
-5% -$550 ﹤0.01% 7892
2020
Q4 		$0 Sell
476
-9,450
-95% -$238K ﹤0.01% 8826
2020
Q3 		$0 Buy
+9,926
New +$268K ﹤0.01% 8235
2020
Q2 		– Sell
-7,946
Closed -$466K – 8084
2020
Q1 		$382K Buy
7,946
+5,491
+224% +$331K ﹤0.01% 2888
2019
Q4 		$139K Buy
2,455
+1,012
+70% +$44.6K ﹤0.01% 4141
2019
Q3 		$89K Buy
1,443
+1,285
+813% +$72.8K ﹤0.01% 4450
2019
Q2 		$7K Buy
+158
New +$7.91K ﹤0.01% 6299
2018
Q4 		– Sell
-348
Closed -$25.5K – 7541
2018
Q3 		$34K Buy
348
+321
+1,189% +$24.1K ﹤0.01% 5527
2018
Q2 		$1K Buy
+27
New +$1.64K ﹤0.01% 7176
2017
Q4 		– Sell
-50
Closed -$3K – 6429
2017
Q3 		$3K Sell
50
-1,454
-97% -$83.4K ﹤0.01% 4819
2017
Q2 		$106K Buy
+1,504
New +$97.3K ﹤0.01% 1712

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's NERV Position: Q3 2022 in Review

Simplex Trading sold out of Minerva Neurosciences (NERV) in Q3 2022, closing a stake of 251 shares.

Simplex Trading first reported a position in NERV in Q2 2017 and held it in 13 quarters. The position peaked at $382K in Q1 2020. 25 funds tracked by Wall St. Rank hold NERV as of Q3 2022.

  • Simplex Trading reported no remaining Minerva Neurosciences position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 251 Minerva Neurosciences shares in Q3 2022.
  • Simplex Trading first reported a position in Minerva Neurosciences in Q2 2017 and held it in 13 quarters.
  • Simplex Trading's Minerva Neurosciences position peaked at $382K in Q1 2020.
  • 25 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.